A Canadian pharmaceutical company with 9 billion Lrb Euro444 million Rrb in annual sales will lose up to 9 billion Lrb Euro4 .5 billion Rrb if a judge forces it to withdraw its generic version of blood thinner Plavix from the market, a financial expert for the company testified Monday.
Accountant says Plavix case could cost company 9 billion.